Baxter ($BAX) is facing a new set of regulator entanglements related to the infusion pumps that were yanked from the market two years ago because manufacturing issues ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. A voluntary safety recall of widely used Alaris infusion ...

Please provide your email address to receive an email when new articles are posted on . The FDA announced a new initiative to address safety problems associated with external infusion pumps and is ...

An unspecified number of ambulatory infusion pumps were recalled because of nearly 3,700 complaints related to several product issues, the FDA said March 20. InfuTronix voluntarily recalled five types ...

Infusion pumps have been plagued with multiple FDA recalls in recent years, and some of the pumps identified in the recalls are still in use, according to a report by DotMed. For example, 200,000 ...

Smiths Medical has been urging healthcare providers to update tens of thousands of its hospital syringe pumps after identifying issues with outdated software, and now the FDA is helping to get the ...

Hospira ($HSP) now faces a Class I recall--the FDA's most serious--because of malfunctioning problems with the company's Symbiq infusion pump system. The designation ...

An FDA consent decree alleges that Medtronic has repeatedly failed to address manufacturing problems related to its Synchromed II implantable infusion pump. First approved in 2004, the device can ...

To data, there have been 13 reported injuries. Becton Dickinson (BD)/Carefusion 303 is recalling the Alaris infusion pump due to incompatibility issues with Cardinal Health Monoject syringes. The Food ...